Basic info
Industry
biotechnology research
Sectors
Biotechnology
drug development
immunology
Cas9
base editing
drug delivery
cell biology
Liver
precision medicines
AAV
mRNA Production
protein sciences
DNA
genetic diseases
vector production
rare diseases
hematology
Genetics
formulation development
RNA
gene therapy
cell therapy
LNP
gene editing
ex vivo
lipid nanoparticles
In vivo
structural biology
CRISPR Cas9
virology
Therapeutics
mRNA
Medical
CRISPR
nanoparticles formulation
viral delivery
Date founded
2017
Funding rounds raised
Total raised
$260M
from 12 investors over 12 rounds
B
Beam Therapeutics raised $260M on January 19, 2021
Investors: Farallon Capital Management, Casdin Capital, LLC, Perceptive Advisors and Redmile Group
B
Beam Therapeutics raised $135M on March 6, 2019
Investors: Omega Funds, F-Prime Capital Partners, Redmile Group, ARCH Venture Partners and GV
B
Beam Therapeutics raised $87M on May 14, 2018
Investors: Osage University Partners (OUP), ARCH Venture Partners and F-Prime Capital Partners